US Stock MarketDetailed Quotes

VRNA Verona Pharma

Watchlist
  • 37.860
  • -0.990-2.55%
Close Nov 21 16:00 ET
  • 38.940
  • +1.080+2.85%
Pre 08:00 ET
3.10BMarket Cap-18930P/E (TTM)

Verona Pharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
5.62M
0
0
0
0
0
0
0
-98.86%458K
458K
Operating revenue
--5.62M
--0
--0
--0
--0
--0
--0
--0
-98.86%458K
--458K
Cost of revenue
543K
0
0
0
346K
Gross profit
5.08M
0
0
0
-99.72%112K
Operating expense
165.56%44.14M
467.91%67.58M
33.83%26.61M
0.36%66.47M
25.72%18.06M
27.84%16.62M
-21.19%11.9M
-16.32%19.89M
-32.20%66.23M
-38.85%14.37M
Selling and administrative expenses
163.58%35.2M
294.20%49.04M
113.10%20.43M
89.45%50.35M
79.89%14.97M
152.42%13.35M
125.10%12.44M
28.88%9.59M
-21.61%26.58M
44.57%8.32M
Research and development costs
256.73%10.55M
883.67%19.39M
-46.36%6.76M
-65.07%17.22M
-39.72%4.12M
-69.93%2.96M
-116.51%-2.47M
-28.45%12.61M
-37.94%49.28M
-69.89%6.84M
Other taxes
-621.68%-1.61M
-143.80%-847K
74.71%-585K
88.54%-1.1M
-29.90%-1.03M
114.53%309K
135.76%1.93M
-77.65%-2.31M
38.36%-9.63M
84.00%-796K
Operating profit
-134.99%-39.06M
-467.91%-67.58M
-33.83%-26.61M
-0.53%-66.47M
-26.71%-18.06M
-27.84%-16.62M
21.19%-11.9M
16.32%-19.89M
-14.62%-66.12M
39.33%-14.25M
Net non-operating interest income expense
-271.70%-5.13M
-48.05%1.38M
-24.83%1.79M
365.39%10.7M
63.54%2.67M
350.83%2.99M
3,497.30%2.66M
3,555.07%2.38M
805.52%2.3M
2,090.24%1.63M
Non-operating interest income
40.12%4.75M
-7.70%3.14M
26.19%3.38M
352.36%12.76M
76.80%3.29M
335.17%3.39M
1,961.82%3.4M
17,746.67%2.68M
20,050.00%2.82M
61,966.67%1.86M
Non-operating interest expense
2,364.34%9.88M
137.43%1.76M
441.30%1.59M
294.82%2.06M
170.87%623K
245.69%401K
713.19%740K
248.81%293K
53.24%521K
170.59%230K
Other net income (expense)
245.75%1.48M
-590.27%-3.63M
-123.50%-219K
140.28%1.87M
-45.13%1.21M
68.81%-1.01M
127.80%740K
200.98%932K
-291.25%-4.63M
3,503.28%2.2M
Gain on sale of security
245.75%1.48M
-96.62%25K
-123.50%-219K
148.89%1.87M
-59.97%1.21M
68.81%-1.01M
127.80%740K
200.98%932K
-257.60%-3.82M
4,839.34%3.01M
Special income (charges)
--0
---3.65M
----
--0
--0
--0
--0
----
---815K
----
-Less:Other special charges
----
--3.65M
----
----
----
----
----
----
--815K
----
Income before tax
-191.69%-42.71M
-721.71%-69.82M
-51.12%-25.04M
21.26%-53.9M
-36.09%-14.19M
6.03%-14.64M
51.96%-8.5M
33.06%-16.57M
-23.14%-68.45M
55.67%-10.42M
Income tax
468.18%250K
227.10%1.01M
335.84%754K
87.35%474K
-289.29%-53K
-31.25%44K
292.41%310K
110.98%173K
1,505.56%253K
111.20%28K
Net income
-192.52%-42.96M
-704.30%-70.84M
-54.06%-25.79M
20.86%-54.37M
-35.22%-14.13M
6.14%-14.69M
50.43%-8.81M
32.59%-16.74M
-23.63%-68.7M
55.07%-10.45M
Net income continuous Operations
-192.52%-42.96M
-704.30%-70.84M
-54.06%-25.79M
20.86%-54.37M
-35.22%-14.13M
6.14%-14.69M
50.43%-8.81M
32.59%-16.74M
-23.63%-68.7M
55.07%-10.45M
Minority interest income
Net income attributable to the parent company
-192.52%-42.96M
-704.30%-70.84M
-54.06%-25.79M
20.86%-54.37M
-35.22%-14.13M
6.14%-14.69M
50.43%-8.81M
32.59%-16.74M
-23.63%-68.7M
55.07%-10.45M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-192.52%-42.96M
-704.30%-70.84M
-54.06%-25.79M
20.86%-54.37M
-35.22%-14.13M
6.14%-14.69M
50.43%-8.81M
32.59%-16.74M
-23.63%-68.7M
55.07%-10.45M
Basic earnings per share
-250.00%-0.56
-1,000.00%-0.88
-33.33%-0.32
30.77%-0.72
-200.00%-0.24
33.33%-0.16
75.00%-0.08
40.00%-0.24
-8.33%-1.04
80.00%-0.08
Diluted earnings per share
-250.00%-0.56
-1,000.00%-0.88
-33.33%-0.32
30.77%-0.72
-200.00%-0.24
33.33%-0.16
75.00%-0.08
40.00%-0.24
-8.33%-1.04
80.00%-0.08
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 5.62M0000000-98.86%458K458K
Operating revenue --5.62M--0--0--0--0--0--0--0-98.86%458K--458K
Cost of revenue 543K000346K
Gross profit 5.08M000-99.72%112K
Operating expense 165.56%44.14M467.91%67.58M33.83%26.61M0.36%66.47M25.72%18.06M27.84%16.62M-21.19%11.9M-16.32%19.89M-32.20%66.23M-38.85%14.37M
Selling and administrative expenses 163.58%35.2M294.20%49.04M113.10%20.43M89.45%50.35M79.89%14.97M152.42%13.35M125.10%12.44M28.88%9.59M-21.61%26.58M44.57%8.32M
Research and development costs 256.73%10.55M883.67%19.39M-46.36%6.76M-65.07%17.22M-39.72%4.12M-69.93%2.96M-116.51%-2.47M-28.45%12.61M-37.94%49.28M-69.89%6.84M
Other taxes -621.68%-1.61M-143.80%-847K74.71%-585K88.54%-1.1M-29.90%-1.03M114.53%309K135.76%1.93M-77.65%-2.31M38.36%-9.63M84.00%-796K
Operating profit -134.99%-39.06M-467.91%-67.58M-33.83%-26.61M-0.53%-66.47M-26.71%-18.06M-27.84%-16.62M21.19%-11.9M16.32%-19.89M-14.62%-66.12M39.33%-14.25M
Net non-operating interest income expense -271.70%-5.13M-48.05%1.38M-24.83%1.79M365.39%10.7M63.54%2.67M350.83%2.99M3,497.30%2.66M3,555.07%2.38M805.52%2.3M2,090.24%1.63M
Non-operating interest income 40.12%4.75M-7.70%3.14M26.19%3.38M352.36%12.76M76.80%3.29M335.17%3.39M1,961.82%3.4M17,746.67%2.68M20,050.00%2.82M61,966.67%1.86M
Non-operating interest expense 2,364.34%9.88M137.43%1.76M441.30%1.59M294.82%2.06M170.87%623K245.69%401K713.19%740K248.81%293K53.24%521K170.59%230K
Other net income (expense) 245.75%1.48M-590.27%-3.63M-123.50%-219K140.28%1.87M-45.13%1.21M68.81%-1.01M127.80%740K200.98%932K-291.25%-4.63M3,503.28%2.2M
Gain on sale of security 245.75%1.48M-96.62%25K-123.50%-219K148.89%1.87M-59.97%1.21M68.81%-1.01M127.80%740K200.98%932K-257.60%-3.82M4,839.34%3.01M
Special income (charges) --0---3.65M------0--0--0--0-------815K----
-Less:Other special charges ------3.65M--------------------------815K----
Income before tax -191.69%-42.71M-721.71%-69.82M-51.12%-25.04M21.26%-53.9M-36.09%-14.19M6.03%-14.64M51.96%-8.5M33.06%-16.57M-23.14%-68.45M55.67%-10.42M
Income tax 468.18%250K227.10%1.01M335.84%754K87.35%474K-289.29%-53K-31.25%44K292.41%310K110.98%173K1,505.56%253K111.20%28K
Net income -192.52%-42.96M-704.30%-70.84M-54.06%-25.79M20.86%-54.37M-35.22%-14.13M6.14%-14.69M50.43%-8.81M32.59%-16.74M-23.63%-68.7M55.07%-10.45M
Net income continuous Operations -192.52%-42.96M-704.30%-70.84M-54.06%-25.79M20.86%-54.37M-35.22%-14.13M6.14%-14.69M50.43%-8.81M32.59%-16.74M-23.63%-68.7M55.07%-10.45M
Minority interest income
Net income attributable to the parent company -192.52%-42.96M-704.30%-70.84M-54.06%-25.79M20.86%-54.37M-35.22%-14.13M6.14%-14.69M50.43%-8.81M32.59%-16.74M-23.63%-68.7M55.07%-10.45M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -192.52%-42.96M-704.30%-70.84M-54.06%-25.79M20.86%-54.37M-35.22%-14.13M6.14%-14.69M50.43%-8.81M32.59%-16.74M-23.63%-68.7M55.07%-10.45M
Basic earnings per share -250.00%-0.56-1,000.00%-0.88-33.33%-0.3230.77%-0.72-200.00%-0.2433.33%-0.1675.00%-0.0840.00%-0.24-8.33%-1.0480.00%-0.08
Diluted earnings per share -250.00%-0.56-1,000.00%-0.88-33.33%-0.3230.77%-0.72-200.00%-0.2433.33%-0.1675.00%-0.0840.00%-0.24-8.33%-1.0480.00%-0.08
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data